IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV10I11A224

Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?

Vasim Farooq, MBChB, MRCP, PhD; Mamas A. Mamas, MA, DPhil, BM BCh, MRCP; Douglas G. Fraser, MB BChir, BA, FRCP, DM; Magdi El-Omar, BSc, MBBS, MRCP, MD; Bernard Clarke, BSc, MBChB, MD, FRCP, FESC, FACC; Farzin Fath-Ordoubadi*, BSc, MB BChir, MD, FRCP

Severe drug-eluting stent in-stent restenosis (ISR) in the left anterior descending (LAD) artery was treated with a 3.0×28 mm Absorb bioresorbable vascular scaffold (Absorb BVS; Abbott Vascular, Santa Clara, CA, USA). Seven-month scheduled angiography demonstrated no significant change with a fully patent treated LAD vessel with TIMI (Thrombolysis In Myocardial Infarction) 1 flow in the septal branch (Figure 1A).

Figure 1. Baseline and seven-month coronary angiography and optical coherence tomography of drug-eluting stent-in-stent restenosis treated with the Absorb BVS.

Potential advantages of the Absorb BVS for the treatment of ISR include avoidance of multiple permanent metallic stent layers, limus-based drug elution, and allowances to treat disease beyond the stent margins.

Seven-month optical coherence tomography demonstrated incomplete healing, with a lack of a smooth luminal contour and multiple uncovered Absorb struts overlapped with metallic struts (Figure 1B). The thicker Absorb struts (156 μm), similar in thickness to first-generation drug-eluting stents, create alterations in shear stress (high shear stress on top of the strut and low shear stress behind the strut) that predisposes to a greater neointimal response and possible triggering of platelet aggregation. Furthermore, porcine studies have shown healing of overlapping Absorb BVS (strut thickness >300 microns) to be delayed at 30 days and completed at 90 days (equivalent to approximately six and 18 months in humans, respectively). In addition, the possibility of localised drug toxicity leading to delayed healing cannot be excluded: for example, most of the antiproliferative drug remains sequestered in the durable polymer of the first-generation TAXUS drug-eluting stent (Boston Scientific, Marlborough, MA, USA). Randomised trials are required to establish the potential safety and efficacy of the Absorb BVS for the treatment of ISR and the duration of dual antiplatelet therapy.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 10 Number 11
Mar 20, 2015
Volume 10 Number 11
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV11I1A14 May 19, 2015
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity
Azzalini L et al
free

10.4244/EIJV11I12A259 Mar 18, 2016
Oversized post-dilatation of current bioresorbable vascular scaffolds: kill or cure?
von Birgelen C and Basalus M
free

10.4244/EIJV13I7A115 Sep 20, 2017
Bioresorbable scaffolds: reflections after a setback - losing a battle does not mean losing the war!
Colombo A and Azzalini L
free

10.4244/EIJV14I9A176 Oct 12, 2018
The future of vascular restoration therapy
Sabaté M
free
Trending articles
57.8

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
36.35

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
35.15

State-of-the-Art

10.4244/EIJ-D-23-00895 Apr 1, 2024
Percutaneous interventions for pulmonary embolism
Finocchiaro S et al
free
28.5

CLINICAL RESEARCH

10.4244/EIJV11I1A6 May 19, 2015
European expert consensus on rotational atherectomy
Barbato E et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved